We evaluated the therapeutic usefulness of adjuvant chemotherapy in patients with
completely resected non-small cell lung cancer (NSCLC). We also examined the relation …

Eighty‐six patients with non‐small cell lung cancer who underwent curative operations were
postoperatively randomized to control and adjuvant chemotherapy groups. In the adjuvant …

Background: Surgery is the primary treatment for patients with stage I, II, or IIIA non–small-
cell lung cancer (NSCLC). However, long-term survival of NSCLC patients after surgery …

The past decade has witnessed renewed interest in studies exploring the benefits of
adjuvant (postoperative) chemotherapy (±radiation therapy) in patients with resected non …

Two hundred nine patients with completely resected stage III non-small-cell lung cancer
were randomized to Receive postoperative cisplatin and vindesine chemotherapy or no …

Abstract Objective: The West Japan Study Group For Lung Cancer Surgery (WJSG)
conducted a randomized controlled trial in order to assess the usefulness of adjuvant …

N ALL STAGES of completely rejected non-smallcell lung cancer, the most frequent sites of
failure are systemic rather than local." 2 Therefore, it follows that to improve the results of …

For many years, surgery alone was the standard treatment for patients with stage I-IIIA non-
small-cell lung cancer (NSCLC). However, recent studies have demonstrated that adjuvant …

PURPOSE:: To evaluate the efficacy of postoperative adjuvant chemotherapy for completely
resected p-stage I non-small cell lung cancer (NSCLC). MATERIALS AND METHODS …

The purpose of this study was to evaluate the efficacy of adjuvant chemotherapy with three
courses of cisplatin and vindesine, in comparison to observation only, for N2 non-small cell …